1 – 10 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
In-depth proteomic analysis and structural modelling of protein-protein interactions identify known and novel molecular binding partners for EMP3 in erythroid cells
(
- Contribution to journal › Published meeting abstract
-
Mark
New sickle cell disease drug approved for use in England – here’s how voxelotor works
2024) In The Conversation(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2023
-
Mark
Recombinant α
1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a
177Lu-DOTATATE Mouse Radiation Model.
(
- Contribution to journal › Article
- 2022
-
Mark
Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34+ cord blood hematopoietic stem cells using a clinically applicable lentiviral vector
(
- Contribution to journal › Article
-
Mark
Targeting elevated heme levels to treat a mouse model for Diamond-Blackfan Anemia
(
- Contribution to journal › Article
-
Mark
Nuclear stabilization of p53 requires a functional nucleolar surveillance pathway
(
- Contribution to journal › Article
-
Mark
Small Molecules Pushing Erythroid/Megakaryocyte Cell Specification Boundaries
(
- Contribution to journal › Article
- 2021
-
Mark
Human radical scavenger α1-microglobulin protects against hemolysis in vitro and α1-microglobulin knockout mice exhibit a macrocytic anemia phenotype
(
- Contribution to journal › Article
-
Mark
Bone marrow transplantation without myeloablative conditioning in a mouse model for Diamond-Blackfan anemia corrects the disease phenotype
(
- Contribution to journal › Article
-
Mark
The active component of ginseng, ginsenoside Rb1, improves erythropoiesis in models of Diamond–Blackfan anemia by targeting Nemo-like kinase
(
- Contribution to journal › Article